# Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance

> **NCT04071613** · PHASE2 · COMPLETED · sponsor: **Melbourne Health** · enrollment: 104 (actual)

## Conditions studied

- Stroke, Acute, Stroke Ischemic

## Interventions

- **DRUG:** Tenecteplase
- **DRUG:** Intravenous tissue plasminogen activator (tPA)

## Key facts

- **NCT ID:** NCT04071613
- **Lead sponsor:** Melbourne Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-20
- **Primary completion:** 2021-11-16
- **Final completion:** 2021-11-16
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2021-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04071613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04071613, "Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04071613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*